Identification of EGFR gene mutations in lung cancer cells is important because certain types of EGFR gene mutations confer resistance to EGFR-TKIs, and the choice of EGFR-TKIs treatment is determined by the type of EGFR gene mutation. This evidence concerns the gene EGFR and lung carcinoma.